Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on D Amino Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101993398B details a green catalytic hydrogenation method for 1,8-diamino-3,6-naphthalene disulfonic acid, offering high purity and eliminating iron sludge waste for reliable supply.
Patent CN109097409A reveals dual-product enzymatic route. High purity D-amino acids and alpha keto acids. Cost-effective supply chain solutions for global pharmaceutical manufacturing.
Patent CN106397239B reveals advanced amino acid ester ionic liquid synthesis offering high stereoselectivity and scalable green manufacturing solutions.
Patent CN101880241A reveals a safer one-pot Curtius rearrangement for Candesartan intermediates, offering significant cost reduction and supply chain reliability for API manufacturers.
Novel Pd/C catalytic method ensures high purity and yield. Reduces steps for pharmaceutical intermediate manufacturing. Reliable supply chain partner.
Patent CN109136298B reveals a dual-enzyme membrane separation process for D-amino acids, offering >99.9% e.e. and scalable green manufacturing solutions.
Discover the patented CN101817766A method for producing metanilic acid. Achieve 100% conversion with recyclable Pd/C catalysts, eliminating iron sludge and reducing costs for dye and pharma intermediates.
Patent CN117326961A offers safer route avoiding cyanide. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN102127021B details a novel solubilization method for bisbenzimidazole salts ensuring high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN111718290B reveals a one-step synthesis for isoindoline-1-carboxylic acid derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel synthesis of phosphonate derivatives with amino acid fragments. Optimized route for antitumor lead compounds offering supply chain stability and high purity.
Patent CN104988531A reveals high-yield electrochemical method. Reduces cost and environmental impact for pharmaceutical intermediates manufacturing globally.
Patent CN104910034A details a novel ruthenium-catalyzed synthesis for high-purity alpha-beta-diamino acid derivatives, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110483388A reveals high-yield synthesis for nicotinic acid derivatives offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102093399B reveals stable boronation reagent synthesis. Offers cost reduction and supply reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN102391243A details a novel 7-step synthesis for Atorvastatin intermediates, eliminating expensive lithium reagents and improving supply chain reliability.
Patent CN1511826A introduces a robust ketone-based route for beta-amino acids, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global pharma.
Patent CN1317481A details a scalable synthetic route for 4,5-diamino shikimic acid derivatives from isophthalic acid, offering significant cost reduction and supply stability for neuraminidase inhibitor manufacturing.
Patent CN1871204A reveals a superior method for synthesizing 2-dihaloacyl-3-amino-acrylic acid esters, offering cost reduction in fungicide manufacturing and enhanced supply chain reliability.
Patent CN110229075A reveals water-based reduction. High yield, low waste. Reliable supplier for pharma intermediates.